Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people.
We're hiring! https://boards.greenhouse.io/atomai
We're hiring! https://boards.greenhouse.io/atomai
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $35M
Investors 2
| Date | Name | Website |
| 27.01.2023 | Playground... | playground... |
| 07.01.2023 | Playground... | playground... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.01.2023 | Series A | $35M | - |
Mentions in press and media 7
| Date | Title | Description |
| 18.12.2023 | Atomic AI Optimizes RNA Therapeutics with Chemical Mapping | Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology ... |
| 28.01.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 28th Jan 2023 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 27.01.2023 | Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases | Atomic AI’s proprietary engine leverages RNA structural biology and AI foundation models to enable the design of RNA-targeting small molecules and RNA-based medicines Atomic AI, a biotechnology company fusing cutting-edge machine learning w... |
| 25.01.2023 | Atomic AI Raises $35M in Series A Financing | Atomic AI, a San Francisco, CA-based biotechnology company combining machine learning with structural biology to unlock RNA drug discovery, raised $35M in Series A funding. The round was led by Playground Global, with participation from 8VC... |
| 25.01.2023 | With new funding, Atomic AI envisions RNA as the next frontier in drug discovery | The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. But one that has flown under the radar, increasingly thought to be key to certain diseases but woefully understudied, is... |
| 25.01.2023 | Atomic AI Launches with $35M Series A | SAN FRANCISCO, CA, Atomic AI, a biotechnology company, launched with a $35 million Series A round led by Playground Global. >> Click here for more funding data on Atomic AI >> To export Atomic AI funding data to PDF and Exce... |
| - | Atomic AI | “AI-driven RNA drug discovery, with atomic precision” |